Skip to content

Repligen RGEN Net margin

Net margin at other companies

TEC
Bio-TechneTECH
10.9%-6.7pp
Revvity logo
RevvityRVTY
8.3%-2.1pp
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
15.2%+1.0pp
Danaher logo
DanaherDHR
14.9%-0.9pp
Agilent Technologies logo
Agilent TechnologiesA
19.6%+2.0pp
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
6.5%+3.4pp

Other financials

Income statement

See full
Revenue$194.3M+14.8%
Gross profit$108.3M+18.5%
Operating income$15.9M+142%
Net income$8.3M+42.9%
EPS (diluted)$0.15+50.0%

Balance sheet

See full
Cash & equivalents$582.7M-16.4%
Total debt$687.6M+346%
Total equity$2.1B+6.0%
Total assets$2.9B+2.8%

Cash flow

See full
Operating cash flow$28.3M+88.6%
CapEx$4.7M+32.2%
Free cash flow$23.6M+106%

Valuation

See full
Market cap$7.45B-7.1%
Enterprise value$7.55B+2.1%
P/E144.9×
P/S10.1×-0.1×

Profitability

See full
Gross margin49.5%+2.7pp
Operating margin1.5%-14.0pp
FCF margin21.2%+6.1pp

Returns & leverage

See full
Return on equity2.5%+1.9pp
Debt / equity0.3×+0.2×
Current ratio9.2×+2.4×

Where this comes from

Calculated from Repligen’s reported figures.

Based on trailing twelve months.

The official record: Repligen’s 10-Q, filed October 31, 2023, on SEC EDGAR. View the filing →

Ask your AI about Repligen's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Repligen's net margin?
Repligen (RGEN) reported net margin of 17.1% in Q3 2023.
How has Repligen's net margin changed year-over-year?
Repligen's net margin decreased by 17.6% year-over-year, from 20.8% to 17.1%.
What is the long-term trend for Repligen's net margin?
Over 2 years (2020 to 2022), Repligen's net margin has grown at a 19.1% compound annual growth rate (CAGR), from 16.4% to 23.2%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.